DUBLIN–( )–The “Asia Pacific Ophthalmic Drug Shipping System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Country: Trend Forecast plus Growth Opportunity” report has been added to ResearchAndMarkets. com’s offering.

Asia Pacific ophthalmic drug delivery system market will grow by 8. 9% annually with a total addressable market cap associated with $56, 139. 1 million over 2022-2031, driven simply by the growing prevalence regarding ophthalmic diseases, the emerging novel ocular drug shipping systems, rise in number involving ophthalmic procedures that require attentive post procedural care, in addition to the increasing demand to deliver controlled dosage forms for pediatric and even geriatric population.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints together with Challenges
  • Growing Product Trends & Market Opportunities
  • Porter’s Fiver Forces

Based on Product, the Asian countries Pacific market is segmented into the particular following sub-markets with annual revenue ($ mn) with regard to 2021-2031 included in each section.

  • Pre-filled Syringes
  • Multidose Eyedroppers
  • Squeeze Dispensers
  • Mist Sprayers
  • Contact Lenses
  • Ocular Inserts
  • Intraocular Implants
  • Punctal Plugs
  • Other Products

Based on Dosage Form, the Parts of asia Pacific marketplace is segmented into typically the following sub-markets with annual revenue ($ mn) regarding 2021-2031 incorporated in every section.

  • Solutions
  • Gels
  • Ointments
  • Suspensions
  • Emulsions
  • Liposomes & Nanoparticles

Simply by Disease, this Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Glaucoma
  • Diabetic Retinopathy
  • Cataract
  • Dry Eye Syndrome
  • Macular Degeneration
  • Diabetic Macular Edema
  • Refractive Issues
  • Other Illnesses

By simply Setting, often the Asia Pacific market is segmented into the subsequent sub-markets along with annual income ($ mn) for 2021-2031 included in each and every section.

  • Hospitals
  • Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers (ASCs)
  • Some other Configurations

Geographically, the following national/local markets are fully investigated:

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and additionally Philippines)

Selected Key Players

  • Aero Pump GmbH
  • Allergan plc.
  • AptarGroup, Inc.
  • Becton, Dickinson not to mention Company
  • Biocorp
  • Clearside Biomedical, Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Gaplast GmbH
  • Gerresheimer AG
  • Jotteq Incorporation.
  • Kedalion Therapeutics, Inc.
  • Mati Therapeutics, Inc.
  • Nemera
  • Nipro Corporation
  • Visor Therapeutix, Incorporation.
  • Ocumedic, Inc.
  • Owen Mumford
  • Re-Vana Therapeutics
  • Silgan Holdings Inc.
  • Terumo Company
  • Valeant Pharmaceuticals International Inc. (Bausch Health Company)
  • West Pharmaceutical Services, Incorporation.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

3 Segmentation of Asia Pacific Marketplace by Item

4 Segmentation of Asian countries Pacific Industry by Dosage Form

5 Segmentation connected with Asia Pacific cycles Market by simply Illness

6 Segmentation with Asia Ocean Market by means of Setting

7 Asia-Pacific Market place 2021-2031 by way of Country

8 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/vmbl7q

Leave a Reply

Your email address will not be published.